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It is truly a pleasure and privilege to introduce this year’s
recipient of the William Allan Award, Arthur L. Beaudet,
who is the Henry and Emma Meyer Professor and Chair-
man of the Department of Molecular and Human Genet-
ics at the Baylor College of Medicine, in Houston, Texas.
Art earned his ﬁrst degree from the College of the Holy
Cross and his M.D. from Yale University, graduating
from both with honors. After internship and residency
on the Harriet Lane Pediatric Service at the Johns Hopkins
Hospital, he went to the National Institutes of Health to
do research at a time when there was tremendous poli-
tical turmoil in our country with the Vietnam War. His
lab mates and colleagues at the NIH included Joe Gold-
stein (a former recipient of this award), Tom Caskey,
Ed Skolnick, and Marshall Nirenberg; Art worked on
very basic mechanisms of protein translation. In 1971,
he came to the Baylor College of Medicine, where he
has spent almost 37 years contributing to human and
medical genetics and the last 13 years as our leader as Chair
of the Department.
I ﬁrst met Art 22 years ago when I came to Baylor to in-
terview for my Pediatric residency and clinical genetics fel-
lowship. In my greater than two decades there, Art has
been an inspiration, a great mentor, and a terriﬁc leader.
However, we his colleagues, collaborators, and friends in
the Society for whom he was a former president recognize
him today for his scientiﬁc contributions.1032 The American Journal of Human Genetics 82, 1032–1033, MayWilliam Allan was a pioneering human/medical geneti-
cist whose primary ‘‘high-tech’’ experimental approach
for research was pedigree analysis. I thought this would
be fun to mention since all of us who did our clinical train-
ing with Art were drilled by Art until we got the pedigree
correct. I made this slide from one of William Allan’s
papers1, where he posited two rules from such pedigree
studies. (1) Regarding diseases due to a single gene defect, a
survey of 50–100 families usually shows a triple pattern of
inheritance: dominant, recessive, and X-linked. I think
this is perhaps the ﬁrst recognition of genetic heterogene-
ity. (2) The pattern of inheritance determines the age of
onset and clinical severity as demonstrated by Charcot-
Marie-Tooth disease (CMT). Allan made many important
observations on CMT and retinitis pigmentosa.
The Allan Award is given by our Society ‘‘to recognize
substantial and far-reaching scientiﬁc contributions to
human genetics, carried out over a sustained period of sci-
entiﬁc inquiry and productivity’’. Art Beaudet began his
research career with fundamental studies on protein syn-
thesis.2,3 During the next four decades, amongmany other
research accomplishments, he delineated the molecular
genetics of inborn errors of metabolism, focusing on urea
cycle defects, for which he has also worked on gene ther-
apy.4–6
Art also described the ﬁrst case of uniparental disomy
(UPD) as a genetic mechanism for disease, which was
published in our Society’s Journal.7 The full contribution of
the UPD mechanism to disease may become even more
realized as we see better array-based genomic assays app-
lied in the clinic. Art has actively pursued imprinting
in Prader-Willi and Angelman syndromes8–10 and more
recently in autism as one aspect of his mixed epigenetic,
genetic, de novo and inherited, or so-called MEGDI,
model.11,12 I imagine that William Allan would have loved
this model to explain genetic heterogeneity in autism.
Finally, Art spearheaded the clinical implementation of
high-resolution genome analysis by array comparative
genomic hybridization.13–15
His sustainedperiod of scientiﬁc inquiry andproductivity
spans four decades and includes over 300 publications and
the training of about 70 postdoctoral fellows and 10 gradu-
ate students in his own laboratory. Moreover, as director for
more than 30 years of the largest clinical genetics training
program, he has overseen the training of greater than 120
clinical genetics fellows fromtheUnitedStates and through-
out the world including fellows from over 25 countries.1Department of Molecular and Human Genetics, Baylor College of Medicine, One Baylor Plaza, Houston, TX 77030, USA
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I want to personally thank the Society for the wisdom of
its choice. William Allan would have been proud of Art’s
pedigree analysis. I know we will all enjoy hearing Art’s
perspective.
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